SCHEMBL21468449

SCHEMBL21468449

COc1cc2c(cc1NC(=O)c1cnc(C(C)(C)C)nc1)CCCCC2

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.69
▸ MAPT P10636 5/20 0.67
▸ LMNA P02545 3/20 0.67
▸ ALDH1A1 P00352 3/20 0.67
▸ SMN1; SMN2 Q16637 3/20 0.67
▸ HTT P42858 2/20 0.67
▸ HPGD P15428 1/20 0.67
▸ KDM4E B2RXH2 2/20 0.57
▸ CYP1A2 P05177 2/20 0.57
▸ CYP3A4 P08684 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ RAB9A P51151 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.43
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21499392 0.86 MAPT (0.53) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468469 0.82 DHODH (0.71) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468457 0.82 DHODH (1.00) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468513 0.79 DHODH (0.69) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468460 0.79 DHODH (0.59) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468478 0.79 DHODH (0.84) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468491 0.78 DHODH (0.79) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468511 0.78 DHODH (0.75) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21499320 0.77 DHODH (0.77) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468502 0.76 DHODH (0.76) DHODHMAPTLMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 — — US disclosed
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450263-B2 Benzo annulenes as antiviral agents MAVS, ZC3HAV1, GABBR1 DHODH 593/4885MAPT 760/4885LMNA 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback